Cleerly, a leading innovator in the field of cardiovascular disease diagnosis, today announced the launch of the TRANSFORM trial at the American Heart Association's (AHA) 2023 Scientific Sessions. This groundbreaking trial aims to revolutionize the way heart disease is prevented by evaluating a personalized care strategy based on Cleerly's AI-powered coronary artery disease (CAD) plaque staging system.
About the TRANSFORM Trial
The TRANSFORM trial is a randomized, controlled trial that
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Clinical Trial Data Strategy: Shifting to Innovative Data Collection and Flow While Reducing Burden On Your Sites
In drug development, there is a critical focus on protocol design, because it is a key component to running a successful clinical trial. And, in traditional trial design, developing a data management strategy often comes after the protocol is finalized. This can leave study teams juggling between operationalizing the protocol and mapping out optimal data collection and flow in parallel. In today’s complex trial landscape, streamlining planning and processes is top of mind for all stakeholders,
Read More
Fortrea, Medidata Form AI Partnership to Increase Diversity in Clinical Trials
What You Should Know:
- Fortrea, a global contract research organization (CRO), and Medidata, a Dassault Systèmes company specializing in clinical trial solutions, announced an AI-powered partnership to increase diversity in clinical trials.
- The collaboration aims to leverage Medidata's AI technology, specifically Medidata AI Intelligent Trials, to increase access to diverse patients in Fortrea-conducted clinical trials.
Increase Diversity in Clinical Trails
This partnership builds
Read More
M&A: Millar Acquires Sentron; Redefining MEMS Pressure Sensor Industry
What You Should Know:
- Millar, a provider of OEM solutions and a leader in pressure sensor-enabled medical devices for over 54 years, acquires Sentron, a pressure and pH sensor manufacturing company headquartered in Leek, The Netherlands, currently owned by Wellinq.
- The acquisition includes sensor development and fabrication facilities, significantly broadening Millar's capabilities. It enables Millar to expand its product offerings to include pH and electrical conductivity sensors,
Read More
Classiq Launches Quantum Center for Life Sciences with NVIDIA
What You Should Know:
- Classiq, NVIDIA, and Tel Aviv Sourasky Medical Center have established a new initiative, the Quantum Computing for Life Sciences & Healthcare Center, to develop and implement quantum algorithms and applications in these domains.
- The center will focus on areas such as drug discovery, molecular analysis, and bespoke medical treatment strategies. It will also explore the use of quantum computing for optimizing pharmaceutical supply chains and streamlining patient
Read More
Corundum Neuroscience Launches Neuroscience Venture Builder & Fund
What You Should Know:
- Corundum Neuroscience, formerly Joy Ventures launches a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation.
- The newly rebranded Corundum Neuroscience works with researchers and entrepreneurs with commercially applicable ideas to build and grow companies developing innovative solutions spanning a range of health and disease areas, including anxiety, depression, PTSD, chronic pain, sleep and neurodegenerative
Read More
Accenture, Salesforce Partner on Generative AI for Life Sciences Companies
What You Should Know:
- Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help life sciences companies create sustainable value and drive growth.
- Building on their generative AI collaboration, Accenture and Salesforce will leverage their joint generative AI acceleration hub to develop new solutions and use cases for Salesforce Life Sciences
Read More
Prescribing Trends Surge: Wegovy & Ozempic Gain Popularity, Survey Shows
What You Should Know:
- Prescriptions for the popular weight loss drug Wegovy showed a six-fold increase between December 2022 and June 2023, according to a recent analysis of prescribing trends by DrFirst.
- Prescriptions for Ozempic, the lower-dose version for treating diabetes, increased by 65% during the same period among doctors on the DrFirst prescribing network.
- DrFirst's network includes over 350,000 prescribers across the U.S., including 260,000 doctors, who use their
Read More
Cleveland Clinic Launches Quantum Innovation Catalyzer Program
What You Should Know:
The Cleveland Clinic announced the launch of its Quantum Innovation Catalyzer Program, a competitive program designed for startup companies aiming to explore quantum computing applications in healthcare and life sciences.
- Cleveland Clinic plans to select up to four early- and growth-stage life sciences and healthcare technology companies through a competitive application process.
How The Quantum Innovation Catalyzer Program Works
Awarded startups will
Read More
Survey Shows Burdens on Clinical Research Sites Sharply Increasing Since 2018
What You Should Know:
- Advarra, a prominent player in regulatory review solutions and clinical research technology has released findings from its 2023 Study Activation Survey. Since 2018, nearly 60% of clinical research sites have experienced an increase in study volume. The survey reveals sites are also managing more sponsor-provided technology, which is now perceived as a higher burden than contracting and budgeting.
- The 2023 Study Activation Survey aimed to capture the perspectives
Read More
